248 related articles for article (PubMed ID: 18496242)
21. Therapeutic applications of antithrombin concentrates in systemic inflammatory disorders.
Fourrier F
Blood Coagul Fibrinolysis; 1998 Apr; 9 Suppl 2():S39-45. PubMed ID: 9662468
[TBL] [Abstract][Full Text] [Related]
22. [Severe sepsis and septic shock: crossroad between inflammation and coagulation].
Jiménez Ortiz JL; Labarta Monzón L; Armengol Sáez S
Med Clin (Barc); 2002 Jan; 118(2):78. PubMed ID: 11809155
[No Abstract] [Full Text] [Related]
23. Antithrombin III in Sepsis. New evidences and open questions.
Ostermann H
Minerva Anestesiol; 2002 May; 68(5):445-8. PubMed ID: 12029261
[TBL] [Abstract][Full Text] [Related]
24. Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction.
Inthorn D; Hoffmann JN; Hartl WH; Mühlbayer D; Jochum M
Shock; 1997 Nov; 8(5):328-34. PubMed ID: 9361342
[TBL] [Abstract][Full Text] [Related]
25. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
Aibiki M; Fukuoka N; Nishiyama T; Maekawa S; Shirakawa Y
Shock; 2007 Aug; 28(2):141-7. PubMed ID: 17515857
[TBL] [Abstract][Full Text] [Related]
26. Clinical trial results with antithrombin III in sepsis.
Fourrier F; Jourdain M; Tournoys A
Crit Care Med; 2000 Sep; 28(9 Suppl):S38-43. PubMed ID: 11007196
[TBL] [Abstract][Full Text] [Related]
27. Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis.
Hoffmann JN; Mühlbayer D; Jochum M; Inthorn D
Crit Care Med; 2004 Sep; 32(9):1851-9. PubMed ID: 15343012
[TBL] [Abstract][Full Text] [Related]
28. [Antithrombin III in the treatment of sepsis-- new approaches to prescribing the old drug].
Galstian GM; Shutova NA; Gorodetskiĭ VM
Anesteziol Reanimatol; 2007; (6):66-71. PubMed ID: 18326265
[No Abstract] [Full Text] [Related]
29. Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure.
Eisele B; Lamy M
Semin Thromb Hemost; 1998; 24(1):71-80. PubMed ID: 9515782
[TBL] [Abstract][Full Text] [Related]
30. Development of multiple organ failure in critically ill newborns under AT III substitution.
Nováková D; Simák J; Janota J; Stranák Z
Sb Lek; 2000; 101(2):143-8. PubMed ID: 11048489
[TBL] [Abstract][Full Text] [Related]
31. Use of anticoagulants in patients with sepsis.
Langer M; Riccardi F; Piovella F; Klersy C
JAMA; 2002 Jan 23-30; 287(4):448-9. PubMed ID: 11798358
[No Abstract] [Full Text] [Related]
32. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
[TBL] [Abstract][Full Text] [Related]
33. [Therapy with antithrombin III concentrate].
Vinazzer H
Haematologica; 1990; 75 Suppl 2():14-20. PubMed ID: 2201604
[No Abstract] [Full Text] [Related]
34. [Substitution of antithrombin III in shock patients].
Blauhut B; Necek S; Vinazzer H; Bergmann H
Anaesthesist; 1982 Jul; 31(7):349-52. PubMed ID: 7125179
[TBL] [Abstract][Full Text] [Related]
35. Tight glycemic control may favor fibrinolysis in patients with sepsis.
Savioli M; Cugno M; Polli F; Taccone P; Bellani G; Spanu P; Pesenti A; Iapichino G; Gattinoni L
Crit Care Med; 2009 Feb; 37(2):424-31. PubMed ID: 19114908
[TBL] [Abstract][Full Text] [Related]
36. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock.
Mikkelsen ME; Miltiades AN; Gaieski DF; Goyal M; Fuchs BD; Shah CV; Bellamy SL; Christie JD
Crit Care Med; 2009 May; 37(5):1670-7. PubMed ID: 19325467
[TBL] [Abstract][Full Text] [Related]
37. The initial experience of antithrombin III in the management of neonates with necrotizing enterocolitis.
St Peter SD; Little DC; Calkins CM; Holcomb GW; Snyder CL; Ostlie DJ
J Pediatr Surg; 2007 Apr; 42(4):704-8. PubMed ID: 17448770
[TBL] [Abstract][Full Text] [Related]
38. Sepsis, coagulation, and antithrombin: old lessons and new insights.
Levi M; Schouten M; van der Poll T
Semin Thromb Hemost; 2008 Nov; 34(8):742-6. PubMed ID: 19214912
[TBL] [Abstract][Full Text] [Related]
39. Early administration of high-dose antithrombin in severe sepsis: single center results from the KyberSept-trial.
Eid A; Wiedermann CJ; Kinasewitz GT
Anesth Analg; 2008 Nov; 107(5):1633-8. PubMed ID: 18931224
[TBL] [Abstract][Full Text] [Related]
40. The inactivation of antithrombin III by serum elastase in patients with surgical infections.
Cohen JR; Sarfati I; Birnbaum E; Benacquista T; Wise L
Am Surg; 1990 Nov; 56(11):665-7. PubMed ID: 2240857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
